These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27062100)

  • 21. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure.
    Ikeda T; Ikeda K; Nagura M; Taniuchi H; Matsushita M; Kiuchi S; Kuroki Y; Suzuki K; Matsuno N
    Ther Apher Dial; 2004 Aug; 8(4):293-8. PubMed ID: 15274680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
    Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
    Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hemoperfusion using polymyxin B-immobilized fibers on non-shock rat sepsis model.
    Iba T; Okamoto K; Kawasaki S; Nakarai E; Miyasho T
    J Surg Res; 2011 Dec; 171(2):755-61. PubMed ID: 20655065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum cytokine changes induced by direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute respiratory failure.
    Ohashi K; Ito R; Koda R; Iino N; Takada T
    Respir Investig; 2022 Jul; 60(4):585-594. PubMed ID: 35525835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
    Katagiri D; Ishikane M; Asai Y; Izumi S; Takasaki J; Katsuoka H; Kondo I; Ide S; Nakamura K; Nakamoto T; Nomoto H; Akiyama Y; Miyazato Y; Suzuki T; Kinoshita N; Ogawa T; Togano T; Suzuki M; Hashimoto M; Sakamoto K; Kusaba Y; Katsuno T; Fukaya T; Hojo M; Sugiyama M; Mizokami M; Okamoto T; Kimura A; Noiri E; Ohmagari N; Hinoshita F; Sugiyama H
    J Clin Apher; 2021 Jun; 36(3):313-321. PubMed ID: 33325084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis.
    Oishi K; Aoe K; Mimura Y; Murata Y; Sakamoto K; Koutoku W; Matsumoto T; Ueoka H; Yano M
    Intern Med; 2016; 55(24):3551-3559. PubMed ID: 27980253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of polymyxin B hemoperfusion in patients with sepsis requiring continuous hemodiafiltration: Analysis of a nationwide administrative database in Japan.
    Fujimori K; Tarasawa K; Fushimi K
    Ther Apher Dial; 2021 Aug; 25(4):384-389. PubMed ID: 33885232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure.
    Matsuno N; Ikeda T; Ikeda K; Hama K; Iwamoto H; Uchiyama M; Kozaki K; Narumi Y; Kikuchi K; Degawa H; Nagao T
    Ther Apher; 2001 Feb; 5(1):36-9. PubMed ID: 11258608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia: The relation between the disease activity and the serum interleukin-6 level.
    Yasuda H; Ikeda T; Hamaguchi Y; Furukawa F
    J Dermatol; 2017 Oct; 44(10):1164-1167. PubMed ID: 28543432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hemoperfusion using polymyxin B-immobilized fiber on IL-6, HMGB-1, and IFN gamma in a neonatal sepsis model.
    Hussein MH; Kato T; Sugiura T; Daoud GA; Suzuki S; Fukuda S; Sobajima H; Kato I; Togari H
    Pediatr Res; 2005 Aug; 58(2):309-14. PubMed ID: 16006426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct hemoperfusion with a polymyxin B-immobilized cartridge in intestinal warm ischemia reperfusion.
    Sato H; Oshima K; Arakawa K; Kobayashi K; Yamazaki H; Suto Y; Takeyoshi I
    World J Gastroenterol; 2008 Sep; 14(35):5436-41. PubMed ID: 18803356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome.
    Tsushima K; Kubo K; Yoshikawa S; Koizumi T; Yasuo M; Furuya S; Hora K
    Ther Apher Dial; 2007 Apr; 11(2):138-45. PubMed ID: 17381535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of direct hemoperfusion with a polymyxin B-immobilized fiber column (DHP-PMX therapy) on pulmonary ischemia-reperfusion injury in a canine model.
    Oshima K; Akao T; Kobayashi K; Muraoka M; Matsumoto K; Takeyoshi I
    J Invest Surg; 2008; 21(3):127-32. PubMed ID: 18569432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock.
    Kumagai T; Takeyama N; Yabuki T; Harada M; Miki Y; Kanou H; Inoue S; Nakagawa T; Noguchi H
    Shock; 2010 Nov; 34(5):461-6. PubMed ID: 20386499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of direct hemoperfusion with polymyxin B-immobilized fiber on rapidly progressive interstitial lung diseases.
    Takada T; Asakawa K; Sakagami T; Moriyama H; Kazama J; Suzuki E; Narita I
    Intern Med; 2014; 53(17):1921-6. PubMed ID: 25175123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of different perfusion durations in direct hemoperfusion with polymyxin B-immobilized fiber column therapy for acute exacerbation of interstitial pneumonias.
    Kono M; Suda T; Enomoto N; Nakamura Y; Kaida Y; Hashimoto D; Inui N; Mizuguchi T; Kato A; Shirai T; Nakamura H; Chida K
    Blood Purif; 2011; 32(2):75-81. PubMed ID: 21372564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
    Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of sepsis during MARS treatment in acute on chronic liver failure.
    Novelli G; Morabito V; Pugliese F; Ferretti G; Novelli S; Ianni S; Lai Q; Rossi M; Berloco PB
    Transplant Proc; 2011 May; 43(4):1085-90. PubMed ID: 21620059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.